The IL-6 Signaling Pathway Contributes Critically to the Immunomodulatory Mechanism of Human Decidua-Derived Mesenchymal Stromal Cells

Researchers found that knock-down IL-6 in decidua-derived MSCs reduced the expression of PD-L1 and PD-L2, which are known as classical immune checkpoint inhibitors.